Lipopolysaccharide induces aberrant hypermethylation of Hic-1 in mouse embryonic fibroblasts lacking p53 gene

Anticancer Research

Volumn 28, Issue 4 B, 2008, Pages 2101-2108

  Tatemichi, Masayuki ^a   Hata, Harumi ^a   Tazawa, Iroshi ^b   Nakadate, Toshio ^a  

^a SHOWA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Inflammation; iNOS; LPS; Methylation; p53

Indexed keywords

GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; PROTEIN P16; PROTEIN P53;

ANIMAL CELL CULTURE; ARTICLE; CONTROLLED STUDY; EMBRYO; EXON; FIBROBLAST; GENE; GENOTYPE; HIC 1 GENE; INOS GENE; MOUSE; NONHUMAN; P16 GENE; P53 GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION;

ANIMALS; CYTOSKELETAL PROTEINS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DNA-BINDING PROTEINS; ENZYME INDUCTION; EXONS; FIBROBLASTS; GENES, P16; GENES, P53; INBREEDING; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE II; PROMOTER REGIONS (GENETICS); RNA, MESSENGER;

EID: 49049093618     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Ushijima T and Okochi-Takada E: Aberrant methylations in cancer cells: where do they come from? Cancer Sci 96: 206-211, 2005.
2. Maekita T, Nakazawa K, Mihara M, Nakajima T, Yanaoka K, Iguchi M, Arii K, Kaneda A, Tsukamoto T, Tatematsu M, Tamura G, Saito D, Sugimura T, Ichinose M and Ushijima T: High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 12: 989-995, 2006.
3. Zhu JD: DNA methylation and hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 13: 265-273, 2006.
4. Calvisi DF, Ladu S, Gorden A, Farina M, Lee JS, Conner EA, Schroeder I, Factor VM and Thorgeirsson SS: Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. J Clin Invest 117: 2713-2722, 2007.
5. Mori Y, Cai K, Cheng Y, Wang S, Paun B, Hamilton JP, Jin Z, Sato F, Berki AT, Kan T, Ito T, Mantzur C, Abraham JM and Meltzer SJ: A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer. Gastroenterology 131: 797-808, 2006.
6. Stenvinkel P, Karimi M, Johansson S, Axelsson J, Suliman M, Lindholm B, Heimburger O, Barany P, Alvestrand A, Nordfors L, Qureshi AR, Ekström TJ and Schalling M: Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease? J Intern Med 261: 488-499, 2007.
7. Miremadi A, Oestergaard MZ, Pharoah PD and Caldas C: Cancer genetics of epigenetic genes. Hum Mol Genet 16: R28-49, 2007.
8. Ohshima H, Tatemichi M and Sawa T: Chemical basis of inflammation-induced carcinogenesis. Arch Biochem Biophys 417:3-11, 2003.
9. Hmadcha A, Bedoya FJ, Sobrino F and Pintado E: Methylation-dependent gene silencing induced by interleukin 1beta via nitric oxide production. J Exp Med 190: 1595-1604, 1999.
10. Murata J, Tada M, Iggo RD, Sawamura Y, Shinohe Y and Abe H: Nitric oxide as a carcinogen: analysis by yeast functional assay of inactivating p53 mutations induced by nitric oxide. Mutat Res 379: 211-218, 1997
11. Lundberg P, Welander P, Han X and Cantin E: Herpes simplex virus type 1 DNA is immunostimulatory in vitro and in vivo. J Virol 77: 11158-11169, 2003.
12. Ambs S, Merriam WG, Ogunfusika MO, Bennett WP, Ishibe N, Hussain SP, Tzeng EE, Geller DA, Billiar TR and Harris CC: p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells. Nat Med 4: 1371-1376, 1998.
13. Ambs S, Ogunfusika MO, Merriam WG, Bennett WP, Billiar TR and Harris CC: Up-regulation of inducible nitric oxide synthase expression in cancer-prone p53 knockout mice. Proc Natl Acad Sci USA 95: 8823-8828, 1998.
14. Li CQ, Trudel LJ and Wogan GN: Nitric oxide-induced genotoxicity, mitochondrial damage, and apoptosis in human lymphoblastoid cells expressing wild-type and mutant p53. Proc Natl Acad Sci USA 99: 10364-10369, 2002.
15. McLaughlin LM and Demple B: Nitric oxide-induced apoptosis in lymphoblastoid and fibroblast cells dependent on the phosphorylation and activation of p53. Cancer Res 65: 6097-6104, 2005.
16. Tatemichi M, Tazawa H, Masuda M, Saleem M, Wada S, Donehower LA, Ohgaki H and Ohshima H: Suppression of thymic lymphomas and increased nonthymic lymphomagenesis in Trp53-deficient mice lacking inducible nitric oxide synthase gene. Int J Cancer 111: 819-828, 2004.
17. Sengupta S and Harris CC: p53: traffic cop at the crossroads of DNA repair and recombination. Nat Rev Mol Cell Biol 6: 44-55 ,2005.
18. Chen WY, Zeng X, Carter MG, Morrell CN, Chiu Yen RW, Esteller M, Watkins DN, Herman JG, Mankowski JL and Baylin SB: Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors. Nat Genet 33: 197-202, 2003.
19. Govindarajan B, Klafter R, Miller MS, Mansur C, Mizesko M, Bai X, LaMontagne K Jr and Arbiser JL: Reactive oxygen-induced carcinogenesis causes hypermethylation of p16(INK4a) and activation of MAP kinase. Mol Med 8: 1-8, 2002
20. Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G and Sherr CJ: Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91: 649-659, 1997.
21. Patel AC, Anna CH, Foley JF, Stockton PS, Tyson FL, Barrett JC and Devereux TR: Hypermethylation of the p16(INK4a) promoter in B6C3F1 mouse primary lung adenocarcinomas and mouse lung cell lines. Carcinogenesis 21: 1691-1700, 2000.
22. vom Brocke J, Schmeiser HH, Reinbold M and Hollstein M: MEF immortalization to investigate the ins and outs of mutagenesis. Carcinogenesis 27: 2141-2147, 2006.
23. Rood BR, Zhang H, Weitman DM and Cogen PH: Hypermethylation of HIC-1 and 17p allelic loss in medulloblastoma. Cancer Res 62: 3794-3797, 2002.
24. Chen WY, Wang DH, Yen RC, Luo J, Gu W and Baylin SB: Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses. Cell 123: 437-448, 2005.
25. INK4a gene and methylation pattern of CpG sites in the promoter region in rat tumor cell lines. Mol Carcinog 39: 10-14, 2004.
26. Luo D, Zhang B, Lv L, Xiang S, Liu Y, Ji J and Deng D: Methylation of CpG islands of p16 associated with progression of primary gastric carcinomas. Lab Invest 86: 591-598, 2006.
27. Jicai Z, Zongtao Y, Jun L, Haiping L, Jianmin W and Lihua H: Persistent infection of hepatitis B virus is involved in high rate of p16 methylation in hepatocellular carcinoma. Mol Carcinog 45: 530-536, 2006.
28. NK4A tumor suppressor genes hi oxystress-induced renal cell carcinoma of rats. Oncogene 18: 3793-3797, 1999.
29. Kovalchuk O, Burke P, Besplug J, Slovack M, Filkowski J and Pogribny I: Methylation changes in muscle and liver tissues of male and female mice exposed to acute and chronic low-dose X-ray-irradiation. Mutat Res 548: 75-84, 2004.
30. Kostka G, Urbanek K and Ludwicki JK: The effect of phenobarbital on the methylation level of the p16 promoter region in rat liver. Toxicology 239: 127-135, 2007.
31. Fraga MF and Esteller M: Epigenetics and aging: the targets and the marks. Trends Genet 23: 413-418, 2007.
32. Yang RB, Mark MR, Gray A, Huang A, Xie MH, Zhang M, Goddard A, Wood WI, Gurney AL and Godowski PJ: Toll-like receptor-2 mediates lipopolysaccharide- induced cellular signalling. Nature 395: 284-288, 1998.
33. Valinluck V and Sowers LC: Inflammation-mediated cytosine damage: a mechanistic link between inflammation and the epigenetic alterations in human cancers. Cancer Res 67: 5583-5586, 2007.
34. Mita Y, Dobashi K, Shimizu Y, Nakazawa T and Mori M: Toll-like receptor 2 and 4 surface expressions on human monocytes are modulated by interferon-gamma and macrophage colony-stimulating factor. Immunol Lett 78: 97-101, 2001.
35. +/- mice and lack of response to sulindac. Oncogene 24: 2104-2109, 2005.